In leiomyosarcomas and osteosarcomas, CSF-1R was found to be highly expressed by TAMs, and, in leiomyosarcomas, expression of CSF-1 and related proteins have also been associated with worse clinical outcomes [125,126]. This evidence concerns the gene CSF1 and leiomyosarcoma.